77. Battling rare diseases: patients and scientists, Ethan Perlstein, Founder and CEO, Perlara

episode

Biotech 2050 Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Oura Delays IPO Over Market Uncertainty 2 min · 29 Sep 2026 · WSJ Minute Briefing

Win Brooke's Bucks (9/29/26) 11 min · 29 Sep 2026 · Brooke and Jeffrey

Ex-Disney CEO BREAKS SILENCE on Bob Iger & The Truth About Disney | PBD Podcast #864 1h 59m · 29 Sep 2026 · PBD Podcast

A Relaxing Visit to Ek Balam 44 min · 29 Sep 2026 · Get Sleepy: stories for sleep

Ep. 2070 - Republican Campaign Ad Brutalizes Lazy White Men 51 min · 29 Sep 2026 · The Michael Knowles Show

The Dollar-Store Hour: Why Doing It Yourself is Costing You Millions 3 min · 29 Sep 2026 · The Level Up Podcast w/ Paul Alex

Report any issue

Source

Recorded27 Oct 2021

Publisherfeeds.soundcloud.com ↗

Handlerec:2866910

Show notes

Dr. Ethan Perlstein is the founder and CEO of Perlara PBC, the first biotech public benefit company established in 2014 that partners with highly motivated and entrepreneurial families and foundations to develop treatments and cures for genetic diseases. Ethan is also cofounder and CEO of Maggie's Pearl LLC, a joint venture co-owned by Perlara, a family based in Michigan and the Mayo Clinic that is commercializing a repurposed drug for a congenital disorder of glycosylation. Ethan relaunched Perlara in 2021 as the first fully decentralized, distributed and web3 biotech company.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in